"Reports of My Death Have Been Greatly Exaggerated"
By Osagie K. Obasogie,
The Huffington Post
| 06. 18. 2010
Race and Genetics Ten Years After the Human Genome Project
Ten years ago this month, we were definitively told that race is scientifically invalid, supposedly ending centuries of debate over the social versus biological character of racial categories. At the high profile announcement that a draft sequence of the human genome had been completed, President Clinton said "one of the great truths to emerge from this triumphant expedition inside the human genome is that in genetic terms all human beings, regardless of race, are more than 99.9% the same."
While subsequent research has slightly lowered this initial estimate to around 99.5%, much of the excitement around the Human Genome Project's (HGP) June 2000 announcement focused on this seemingly conclusive finding that social categories of race, as a coherent way of understanding biological differences between human groups, are largely meaningless.
This wasn't the Project's initial goal, which was seen as a landmark scientific achievement akin to landing on the moon. By mapping the complete set of DNA containing the "blueprint" for human life, the Project's intended significance laid in what many thought would be its revolutionary implications for human health: diagnosing...
Related Articles
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
By Carolyn Riley Chapman and Nirvan Bhatia, Hastings Bioethics Forum | 03.12.2026
Last year, researchers saved an infant named KJ from a life-threatening rare metabolic disorder using a customized gene editing therapy. This was the first time that an individualized gene therapy was used to treat a human patient, and it has...
By Alexandra Marquez, NBC News | 03.13.2026
“Donald Trump” by Gage Skidmore is licensed under CC BY-SA 2.0
President Donald Trump on Thursday blamed “the genetics” of assailants in a string of recent attacks across the country. He made the comments after attacks at a...